Cytocom Updates Investigational New Drug Application for Phase 2 Clinical Trial of COVID-19 Treatment

  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • 02/23/2021 at 10:10 am #12274

    Deprecated: Function seems_utf8 is deprecated since version 6.9.0! Use wp_is_valid_utf8() instead. in /home/cobioscience/www/www/wp-includes/functions.php on line 6131

    Deprecated: Function seems_utf8 is deprecated since version 6.9.0! Use wp_is_valid_utf8() instead. in /home/cobioscience/www/www/wp-includes/functions.php on line 6131
    Colorado BioScience AssocationColorado BioScience Association
    Keymaster

    The Fort Collins biopharmaceutical firm submitted the updated IND to the FDA to begin a Phase 2 clinical trial evaluating the safety and efficacy of CYTO-205.

    More Information

  • Author
    Posts
Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.